Literature DB >> 21876950

The experience of thalassemic adults with their treatment.

Marcela Ganzella1, Márcia Maria Fontão Zago.   

Abstract

This study, based on medical anthropology and oral reports, analyzes the meanings attributed by thalassemic adults to their experiences with the treatment. Interviews were used to collect data, which were analyzed through inductive thematic analysis. Eleven young adults, six of whom were men, at different ages, with different educational levels and occupations participated in the study. The meanings are discussed through the theme "the lives of patients with thalassemia in relation to their treatment". This core meaning highlights the difference made in their identity by having the disease trait, the recognition of the importance of adhering to their treatment, the difficulties in maintaining their social functions, the patients' irregular treatment adherence and their justifications for non-adherence to their treatment. Thalassemic patients conform to their condition and employ a normalization strategy to control the disease and justify irregular treatment adherence.

Entities:  

Mesh:

Year:  2011        PMID: 21876950     DOI: 10.1590/s0104-11692011000400016

Source DB:  PubMed          Journal:  Rev Lat Am Enfermagem        ISSN: 0104-1169


  3 in total

1.  Negative affect differentiation and adherence during treatment for thalassemia.

Authors:  Karin G Coifman; Gail S Ross; Dorothy Kleinert; Patricia Giardina
Journal:  Int J Behav Med       Date:  2014-02

2.  Exploring Iranian β-Thalassemia major patients' perception of barriers and facilitators of adherence to treatment: A qualitative study.

Authors:  Amir Emami Zeydi; Hossein Karimi Moonaghi; Abbas Heydari
Journal:  Electron Physician       Date:  2017-12-25

3.  Characterization of thalassemia major and diabetes mellitus patients at a reference center in Brazil.

Authors:  Gabriela Marsola Olivatto; Carla Regina de Souza Teixeira; Marcela Ganzella Sisdelli; Maria Lúcia Zanetti; Renata Cristina de Campos Pereira Silveira; Claudio Vinicius Gonçalves
Journal:  Hematol Transfus Cell Ther       Date:  2018-12-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.